Skip to main content
Kevin Kennedy on Muck Rack

Kevin Kennedy

As seen in: Nature, Wiley Online Library, Memory Studies, JAMA: Journal of the American Medical Association, The New England Journal of Medicine, The Lancet, Annals of Internal Medicine, American Journal of Managed Care, JACC (Journal of the American College of Cardiology), The Journal of Immunology and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kevin

Contact Kevin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A pilot study of pharmacogenomic testing as a tool to enhance depression care in Veterans

|
By Kevin Kennedy, Kevin Lynch, Ryan Bremseth-Vining, Charlotte Williams, Deepak Voora, David W. Oslin
| Nature Verified
Abstract Modest outcomes from pharmacogenomic (PGx) testing in depression may be influenced by low rates of actionable gene-drug interactions. This 12-week pilot pragmatic randomized clinical trial evaluated the effectiveness of selectively targeting PGx testing to depressed Veterans receiving psychiatric polypharmacy with an antidepressant on the Sanford Pharmacogenomics Panel.
Open in Who Shared Issue with article?

Preferences for post‐traumatic osteoarthritis prevention strategies in individuals with anterior cruciate ligament injury

|
By Kevin Kennedy, Lily Waddell Verified, Adam Easterbrook, Jeffrey N. Katz, Kevin Kennedy, Cale Jacobs, Morgan Jones, Faith Selzer, Elena Losina, Liana Fraenkel, Nick Bansback
| Wiley Online Library Verified
Supporting Information Filename Description acr25641-sup-0001-Disclosureform.pdfPDF document, 514.7 KB Disclosure Form acr25641-sup-0002-Supinfo.zipZip archive, 808.9 KB Data S1: Supporting Information
Open in Who Shared View Duplicates (2) Issue with article?

P2Y12 Inhibitor Pretreatment in Non–ST-Segment Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry

|
By Hiroki Ueyama, Kevin Kennedy, Jennifer A. Rymer, Alexander T. Sandhu
| JACC (Journal of the American College of Cardiology)
References 1. "2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: executive summary". J Am Coll Cardiol . 2014;64:2645-2687. 2. "Timing, selection, modulation, and duration of P2Y12 inhibitors for patients with acute coronary syndromes undergoing PCI". JACC Cardiovasc Interv . 2023;16:1-18. 3. "Pre-treatment with oral P2Y12 inhibitors in non-ST-segment elevation acute coronary syndromes: does one size fit all?"JACC Cardiovasc Interv . 2020;13:918-920. 4.
Open in Who Shared Issue with article?
See all 30 articles